CN¥68.05
3.03%
Shanghai, Sep 18, 03:00 pm CST. Closed.
ISIN
CNE100003F01
Symbol
688185

Cansino Biologics Inc-h Stock price

CN¥68.05
+12.11 21.65% 1M
-4.96 6.79% 6M
+5.20 8.27% YTD
-13.95 17.01% 1Y
-9.38 12.11% 3Y
-283.94 80.67% 5Y
-325.06 82.69% 10Y
-325.06 82.69% 20Y
Shanghai, Closing price Fri, Sep 18 2026
+2.00 3.03%
ISIN
CNE100003F01
Symbol
688185
Industry

Is Cansino Biologics Inc-h a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
CN¥10.2b
Enterprise Value
CN¥9.3b
Net debt
positive
Cash
CN¥2.1b
Shares outstanding
230.0m
Valuation (TTM | estimate)
P/E
-
P/S
9.1 | 7.0
EV/Sales
8.3 | 6.4
EV/FCF
negative
P/B
2.1
Dividends
DPS
CN¥0.00
Yield 1Y | 5Y
0.0% | 0.1%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CN¥1.1b | CN¥1.5b
EBITDA
-
EBIT
CN¥-1.0m
Net Income
CN¥-1.0m
Free Cash Flow
CN¥-170.0m
Growth (TTM | estimate)
Revenue
29.0% | 36.7%
EBITDA
-
EBIT
99.6%
Net Income
99.5%
Free Cash Flow
63.3%
Margin
Gross
76.1%
EBITDA
-
EBIT
-0.1%
Net
-0.1%
Free Cash Flow
-15.2%
Financial Health
Equity Ratio
69.0%
Return on Equity
0.6%
ROCE
0.0%
ROIC
0.0%
Debt/Equity
0.2
More
EPS
CN¥0.0
FCF per Share
CN¥-0.7
Short interest
-
Employees
1k
Rev per Employee
CN¥940.0k

Cansino Biologics Inc-h Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Cansino Biologics Inc-h forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Cansino Biologics Inc-h forecast:

Buy
86%
Hold
14%

Financial data from Cansino Biologics Inc-h

Mar '26
+/-
%
1,121 1,121
29% 29%
100%
- Direct Costs 268 268
39% 39%
24%
853 853
26% 26%
76%
- Selling and Administrative Expenses 605 605
5% 5%
54%
- Research and Development Expense 312 312
20% 20%
28%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -1.03 -1.03
100% 100%
0%
Net Profit -1.01 -1.01
100% 100%
0%

In millions CNY.

Don't miss a Thing! We will send you all news about Cansino Biologics Inc-h directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CanSino Biologics Inc is a CN-based company operating in Biotechnology industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,134 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The firm is also engaged in the research and development of pharmaceutical production processes. The firm conducts its business in the domestic and overseas markets.

Head office China
CEO Mr. Yu
Employees 1,134
Website www.cansinotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today